SCHEMBL7687693

SCHEMBL7687693

Cc1cc(=O)[nH]c2c1ccn2-c1ccc(C(C)C)cc1Br

nearest known ligand 0.57

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 7/20 0.36
HCAR1 Q9BXC0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7678313 0.72 CRHR1 (0.44) CRHR1
SCHEMBL7678114 0.71 CRHR1 (0.43) CRHR1
SCHEMBL12589465 0.68 KDM4E (0.59)
SCHEMBL19737586 0.68 LMNA (0.59)
SCHEMBL7676337 0.66 CRHR1 (0.43) CRHR1
SCHEMBL7676384 0.64 CRHR1 (0.46) CRHR1
SCHEMBL23903368 0.63 CRHR1 (0.42) CRHR1
SCHEMBL7678441 0.63 CRHR1 (0.42) CRHR1
SCHEMBL1762674 0.61 LMNA (0.58) CRHR1
SCHEMBL22643826 0.58 AR (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6342503-B1 ANTIDEPRESSANTS, EATING DISORDERS DUPONT PHARMACEUTICALS COMPANY 2002-01-29 US disclosed
US-6107301-A PSYCHOLOGICAL DISORDERS DUPONT PHARMACEUTICALS COMPANY (US) 2000-08-22 US disclosed
WO-1995010506-A1 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-04-20 WO disclosed